Literature DB >> 9473220

Prion protein expression in human leukocyte differentiation.

V C Dodelet1, N R Cashman.   

Abstract

The cellular isoform of the prion protein (PrPC) is a small glycoprotein attached to the outer leaflet of the plasma membrane by a glycosylphosphatidylinositol anchor. This molecule is involved in the pathogenesis of prion diseases in both humans and animals. We have characterized the expression patterns of PrPC during human leukocyte maturation by flow cytometry with monoclonal antibodies to PrPC, the glycan moiety CD15, and the stem cell marker CD34. We observe that prion protein is present on CD34+ bone marrow (BM) stem cells. Although lymphocytes and monocytes maintain PrPC expression throughout their differentiation, PrPC is downregulated upon differentiation along the granulocyte lineage. In vitro retinoic acid-induced differentiation of the premyeloid line HL-60 into granulocyte-like cells mimics the suppression of PrPC in granulocyte differentiation, as both PrPC mRNA and protein are downregulated. These data suggest that selected BM cells and peripheral mononuclear cells may support prion agent replication, because this process is dependent on availability of PrPC. Additionally, retinoic acid-induced extinction of PrPC expression in HL-60 cells provides a potential model to study PrP gene regulation and protein function. Finally, these data suggest the existence of cell-specific glycoforms of PrPC that may determine cellular susceptibility to infection by the prion agent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473220

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Scrapie infectivity in hamster blood is not associated with platelets.

Authors:  Karel Holada; Jaroslav G Vostal; Patrick W Theisen; Claudia MacAuley; Luisa Gregori; Robert G Rohwer
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Expression and knockdown of cellular prion protein (PrPC) in differentiating mouse embryonic stem cells.

Authors:  Oscar A Peralta; William R Huckle; Willard H Eyestone
Journal:  Differentiation       Date:  2011-01       Impact factor: 3.880

Review 3.  Prion potency in stem cells biology.

Authors:  Marilene H Lopes; Tiago G Santos
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

4.  Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

Authors:  Tzu-Hao Wang; Angel Chao; Chia-Lung Tsai; Chih-Long Chang; Shun-Hua Chen; Yun-Shien Lee; Jen-Kun Chen; Yi-Jun Lin; Pi-Yueh Chang; Chin-Jung Wang; An-Shine Chao; Shuenn-Dyh Chang; Ting-Chang Chang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

Review 5.  Cellular biology of prion diseases.

Authors:  D A Harris
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

Review 6.  Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health.

Authors:  M B Coulthart; N R Cashman
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

7.  Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis.

Authors:  Shigeki Tsutsui; Jennifer N Hahn; Trina A Johnson; Zenobia Ali; Frank R Jirik
Journal:  Am J Pathol       Date:  2008-10       Impact factor: 4.307

8.  Perturbation of T-cell development by insertional mutation of a PrP transgene.

Authors:  Mark Zabel; Christina Greenwood; Alana M Thackray; Bruce Pulford; Willem Rens; Raymond Bujdoso
Journal:  Immunology       Date:  2008-10-21       Impact factor: 7.397

9.  A proautophagic antiviral role for the cellular prion protein identified by infection with a herpes simplex virus 1 ICP34.5 mutant.

Authors:  Maria Korom; Kristine M Wylie; Hong Wang; Katie L Davis; Meher S Sangabathula; Gregory S Delassus; Lynda A Morrison
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Cell mediated immune responses against human prion protein.

Authors:  J Bainbridge; B Walker
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.